Developers of the Sinopharm vaccine say an interim analysis has found it to be nearly 80 per cent effective against Covid-19. Photo: EPA-EFE Developers of the Sinopharm vaccine say an interim analysis has found it to be nearly 80 per cent effective against Covid-19. Photo: EPA-EFE
Developers of the Sinopharm vaccine say an interim analysis has found it to be nearly 80 per cent effective against Covid-19. Photo: EPA-EFE
China /  Science

China’s Sinopharm reports strong interim results for its Covid-19 vaccine

  • Few details were released in the announcement but the company is seeking conditional listing from Chinese regulator
  • United Arab Emirates has already reported good results from its interim analysis of late-stage trials

Topic |   Coronavirus pandemic
Simone McCarthyZhuang Pinghui
Simone McCarthy and Zhuang Pinghui in Beijing

Updated: 9:14am, 31 Dec, 2020

Why you can trust SCMP
Developers of the Sinopharm vaccine say an interim analysis has found it to be nearly 80 per cent effective against Covid-19. Photo: EPA-EFE Developers of the Sinopharm vaccine say an interim analysis has found it to be nearly 80 per cent effective against Covid-19. Photo: EPA-EFE
Developers of the Sinopharm vaccine say an interim analysis has found it to be nearly 80 per cent effective against Covid-19. Photo: EPA-EFE
READ FULL ARTICLE